skip to main content
  • Less benefits, more side effects

    Women benefit less from triptans – migraine drugs – than men. In addition, women more often suffer from side effects. This was demonstrated in a study by the LUMC and Erasmus MC. Read more in this interview in Leidsch Dagblad (in Dutch).

  • Can migraine patients benefit from the oral contraceptive pill?

    Each month WOMEN Inc. asks a researcher 5 questions. This month: Antoinette Maassen van den Brink, farmacologist and researcher from the Erasmus MC, about her research on the relationship between hormones and migraine. Read the full article here (in Dutch).

  • Women respond differently to treatment of migraine with triptans than men

    Headache researchers from the Leiden University Medical Center (LUMC) and the Erasmus Medical Center (Erasmus MC) concluded that women more often experience headache recurrences after the intake op triptans and report more side effects. The results have been published in the journal Neurology. See for the full article the LUMC website.

  • News article in Nature: Closing the gender gap in migraine research

    “Terwindt notes that many general practitioners remain unaware of the aura-associated risk of stroke, and prescribe oral contraception as a stabilizing treatment for migraine without full knowledge of the risks or clear evidence of the benefits. “It’s just trial and error,” she says. She and Maassen van den Brink have launched a study to establish more firmly whether hormonal treatment helps manage migraine.” Read the full article here.

  • Women with migraine are more jealous and suffer from cold feet more often

    Hoofdpijnonderzoekers uit het Leids Universitair Medisch Centrum (LUMC) en het (Erasmus MC) trekken deze conclusie in twee nieuwe studies naar de effecten van migraine. De resultaten zijn gepubliceerd in de tijdschriften Journal of Headache and Pain en European Journal of Neurology. Zie ook de berichtgeving hierover op BNR Nieuwsradiode Telegraaf en het AD.

  • The tragic of migraine: there's so much we don't know

    Interview with dr. Maassen van den Brink in NRC (Dutch newspaper). Read the full article here (in Dutch)

  1. Previous
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. Next

Publicaties

Verhagen, I.E., Brandt, R.B., Kruitbosch, C.M.A., MaassenVanDenBrink A, Fronczek R, Terwindt GM. Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study. Journal of Headache and Pain 22, 125 (2021). PubMed.

van Casteren DS, Verhagen IE, BWH van der Arend, EW van Zwet, MaassenVanDenBrink A, Terwindt GM. Comparing perimenstrual and nonperimenstrual migraine attacks using an E-diary. Neurology. 2021 Sep. PubMed.

van Casteren DS, Verhagen IE, Onderwater GL, MaassenVanDenBrink A, Terwindt GM. Sex differences in prevalence of migraine trigger factors: A cross-sectional study. Cephalalgia. 2021 May; 41(6):643-648. PubMed.

van Casteren DS, Kurth T, Danser AHJ, Terwindt GM, MaassenVanDenBrink A. Sex Differences in Response to Triptans: A Systematic Review and Meta-analysis. Neurology. 2021 Jan 26; 96(4):162-170. PubMed.

van Casteren DS, van Willigenburg FAC, MaassenVanDenBrink A, Terwindt GM. Jealousy in women with migraine: a cross-sectional case-control study. The Journal of Headache and Pain. May 2020. PubMed.

van Casteren DS, MaassenVanDenBrink A, Terwindt GM. Migraine and other headache disorders in pregnancy. Handbook of Clinical Neurology. 2020. PubMed.